Erchonia receives patent for noninvasive fat reduction.

Share Article

Erchonia, The World Leader in Low Level Laser Technology, announces that they have received a patent for noninvasive fat reduction.

we are very pleased with the issuance of this latest patent as we have devoted a lot of time and passion creating this category and feel this will give us a huge competitive advantage in this emerging market.

Patent no. US 8, 932,338B2- a noninvasive method of reducing fat from targeted regions of a patient’s body by applying low-level laser energy externally through the skin of the patient to the targeted areas. The laser works by applying sufficient energy to release intracellular fat into the interstitial space. The released intra-cellular fat is removed through the body’s natural functions.

Erchonia has a long list of patents on processes and devices on this technology along with 20 publications. Erchonia created the non-invasive method for site specific fat reduction category with the US FDA when they were the first device to get a 510k market clearance for the Zerona device which proved a 3.5 inch reduction from the waist, hips and thighs in 2 weeks.
Erchonia has gone onto to get an additional 6 non-invasive fat loss claims from the FDA and is now submitting for its eighth indication.

Steven Shanks, President of Erchonia and one of the inventors on the patent stated, “We are very pleased with the issuance of this latest patent as we have devoted a lot of time and passion creating this category and feel this will give us a huge competitive advantage in this emerging market.

The FDA has previously cleared Erchonia’s low level lasers for: non-invasive reduction of cellulite; the non-invasive circumference reduction of the arms; for liposuction and breast augmentation assistance and the reduction of associated pain; the reduction of chronic neck, shoulder and heel pain.

About Erchonia
Erchonia is the global leader in low level laser healthcare applications. Over the last 15 years Erchonia has been conducting research and development with the world’s leading physicians to advance the science of low level lasers. Prior to market introduction, all Erchonia lasers are proven safe and effective through independent clinical trials. Currently thousands of Erchonia’s lasers are used daily to reduce body fat and cellulite, eliminate pain, and treat acne.

For additional information, visit http://www.erchonia.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Charlie Shanks
Erchonia Corp.
+1 (214) 733-5203
Email >
@Erchonia
since: 07/2009
Follow >
Erchonia Corporation
Like >
Visit website